Intervention Review

Drug treatment for spinal muscular atrophy types II and III

  1. Renske I Wadman1,*,
  2. Wendy MJ Bosboom2,
  3. W Ludo van der Pol1,
  4. Leonard H van den Berg1,
  5. John HJ Wokke1,
  6. Susan T Iannaccone3,
  7. Alexander FJE Vrancken1

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 18 APR 2012

Assessed as up-to-date: 8 MAR 2011

DOI: 10.1002/14651858.CD006282.pub4

How to Cite

Wadman RI, Bosboom WMJ, van der Pol WL, van den Berg LH, Wokke JHJ, Iannaccone ST, Vrancken AFJE. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006282. DOI: 10.1002/14651858.CD006282.pub4.

Author Information

  1. 1

    University Medical Center Utrecht, Department of Neurology, Utrecht, Netherlands

  2. 2

    Sint Lucas Andreas Hospital, Department of Neurology, Amsterdam, Netherlands

  3. 3

    University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, Texas, USA

*Renske I Wadman, Department of Neurology, University Medical Center Utrecht, Rudolf Magnus Institute for Neuroscience, Universiteitsweg 100, Utrecht, 3584 CG, Netherlands.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2012


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.